Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability
AssigneeAlfa-Laval Agri International AB
InventorsMagnus Hook, Kjell M. Lindberg, Torkel M. Wadstrom
Life of this patent
Estimating the term…
Abstract
A method for prophylactic treatments of the colonization of a Staphylococcus aureus bacterial strain having the ability to bind to fibronectin in a mammal. The method comprises administering a prophylactic therapeutically active amount of a protein having fibronectin binding properties to a mammal in need of such treatment. The generation of infections, such as mastitis, caused by a Staphylococcus aureus bacterial strain are thereby prevented. The administration may be via vaccination to induce immunization.
Claims3
A method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain having the ability to bind to fibronectin in a mammal comprising administering to a mammal in need of such treatment, a prophylactic therapeutically active amount of a protein having fibronectin binding properties, to prevent the generation of infections caused by a Staphylococcus aureus bacterial strain having the ability to bind to fibronectin, said protein having a molecular weight selected from the group consisting of 87,000 and 165,000.
Dependencies are inferred from the claim text.